Description

α-((1-((2-Ethyl-5,7-Dimethylimidazo(4,5-B)Pyridin-3-Yl)Methyl)-3,5-Dipropylphenyl-4-Yl)Oxy)Phenylacetic Acid is a high-purity, non-peptidic small molecule compound of significant interest in advanced pharmaceutical research and development. Its complex heterocyclic structure makes it a valuable intermediate or active pharmaceutical ingredient (API) for targeting specific biological pathways. This compound is primarily utilized by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in the synthesis of novel therapeutic agents.

Application

• Pharmaceutical Intermediate: A key building block in the synthesis of novel drug candidates, particularly in oncology and metabolic disease research.
• Biochemical Research: Used as a reference standard or probe molecule in enzymatic and receptor binding studies to investigate disease mechanisms.
• Preclinical Development: Serves as a critical material for pharmacokinetic, pharmacodynamic, and toxicology studies during early-stage drug development.
• Fine Chemical Synthesis: Employed in the multi-step synthesis of complex, high-value organic molecules for specialized applications.
• Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for cGMP production of clinical trial materials.

Basic Information

Product Name	α-((1-((2-Ethyl-5,7-Dimethylimidazo(4,5-B)Pyridin-3-Yl)Methyl)-3,5-Dipropylphenyl-4-Yl)Oxy)Phenylacetic Acid
CAS No.	153275-22-0
Molecular Formula	C38H43N3O3
Molecular Weight	589.77 g/mol
Synonyms	153275-22-0; α-((1-((2-Ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)methyl)-3,5-dipropyl-4-hydroxyphenyl)oxy)phenylacetic acid; Phenylacetic acid, α-[[1-[[2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl]methyl]-3,5-dipropyl-4-hydroxyphenyl]oxy]-; (2-((1-((2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)methyl)-3,5-dipropyl-4-hydroxyphenoxy)(phenyl)methyl)acetic acid); Research Grade 153275-22-0
EINECS	Contact for details

Quality Control

Our α-((1-((2-Ethyl-5,7-Dimethylimidazo(4,5-B)Pyridin-3-Yl)Methyl)-3,5-Dipropylphenyl-4-Yl)Oxy)Phenylacetic Acid is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and spectroscopic identification (NMR, IR, MS), to ensure it meets the stringent requirements of pharmaceutical research. A comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and light-sensitive; therefore, containers must be kept tightly sealed in a desiccated environment and away from direct light exposure to maintain stability and purity.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.